Mitologics

Where the EU money came from

Funding by EU programme. Amounts are Mitologics's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• RespiriTBPartner

  Progress new assets (one pre-new molecular entity and one first-time-in-human start) for tuberculosis that act synergistically with bedaquiline, cytochrome bc or cytochrome bd inhibitors

  Horizon 2020 · 2019–2026 · Project on CORDIS ↗

  €147ktheir share
• RespiriNTMPartner

  Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline

  Horizon 2020 · 2019–2027 · Project on CORDIS ↗

  €6ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Kobenhavns UniversitetDenmark · 2 shared projects
• Universiteit LeidenNetherlands · 2 shared projects
• Universiteit AntwerpenBelgium · 2 shared projects
• Academisch Ziekenhuis LeidenNetherlands · 2 shared projects
• Medizinische Universitaet WienAustria · 2 shared projects
• Sorbonne UniversiteFrance · 2 shared projects
• Janssen Pharmaceutica NVBelgium · 2 shared projects
• Ffund BVNetherlands · 2 shared projects
• Bioversys AGSwitzerland · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• antibiotic resistance
• drug discovery
• infectious diseases
• multidrug resistance
• tuberculosis